Switching GLP-1 Medications If semaglutide is not providing the results you want, a provider might suggest switching to a different GLP-1 receptor agonist, such as tirzepatide (the active ingredient in Mounjaro and Zepbound)
Hydration status significantly affects periorbital appearance with dehydration exaggerating dark circles through increased blood viscosity pooling more visibly, skin dullness from reduced cellular hydration making circles more prominent, and impaired lymphatic function allowing fluid retention despite overall dehydration
Warnings Hypersensitivity Reactions Serious hypersensitivity reactions, including anaphylaxis, laryngeal edema, and bronchospasm have been reported following levocarnitine injection administration, mostly in patients with end stage renal disease who are undergoing dialysis
We assessed the risk of suicide or suicide attempts following initiation of GLP-1 RA, DPP-4 inhibitors or SGLT-2 inhibitors, respectively
Uddin TM, Chakraborty AJ, Khusro A, et al
Recalls & Warnings June 22, 2023 FDA Warns Warrior Labz for Selling Products with Steroid-Like Substances and Prescription Drugs On June 12, 2023, the FDA issued a warning letter to Warrior Labz SARMS following inspection of the companys website and social media, which found that the company sold the following products labeled as containing steroid-like substances known as selective androgen receptor modulators